Experimental Therapy Crosses Blood-Brain Barrier To Treat Neurological Disease?
Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice. Posted online in PNAS Early Edition on Feb. 4, the study was led by scientists at Cincinnati Children's Hospital Medical Center...
Indique esta NotÃcia
Compartilhar
